Loading…
Company strengthens intellectual property portfolio.
Femasys Inc. (Nasdaq: FEMY) announced the issuance of a new patent by the United States Patent and Trademark Office. The patent enhances the company's intellectual property portfolio, providing additional protection for its innovative medical technologies.
The newly granted patent is expected to support Femasys' ongoing development and commercialization efforts in the medical instruments and supplies sector. With a free float of 2,495,041 shares, Femasys continues to solidify its market position.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.